Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

Sucampo Pharmaceuticals, Inc. (SCMP) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Sucampo Pharmaceuticals is an international pharmaceutical company focused on the innovative research, discovery, development and commercialization of proprietary drugs that are based on prostones. Prostones occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Senesco Technologies, Inc. (SNT) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Senesco Technologies is focused on the development of cancer therapeutics. The company’s platform technology is based on the discovery that eIF5A (Factor 5A) – a gene highly conserved from plants to people – is capable of regulating programmed cell death … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Metabolix, Inc. (MBLX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Metabolix is a bioscience company specializing in the development of clean, sustainable solutions for plastics, chemicals and energy. The company is currently developing Mirel and Mvera, a family of high-performance bioplastics that are biobased and biodegradable alternatives to many petroleum-based … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Butler National Corporation (BUKS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Butler National operates in the business segments of aerospace and services. The company’s aerospace segment is focused on manufacturing support systems for “Classic” commercial and military aircraft. The company’s services segment includes electronic monitoring of water pumping stations, temporary employee … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Cleveland BioLabs, Inc. (CBLI) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Cleveland BioLabs is a clinical-stage biotechnology company focused on leveraging deep mechanistic understanding of apoptosis – the cell death process – in developing a strong pipeline of compounds chiefly focused on oncology applications and mitigation of radiation injury. The company’s … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

BioLineRX Ltd. (BLRX) Reveals Preclinical Results Demonstrating Safety of Oral Treatment for Celiac Disease

BioLineRx is a biopharmaceutical development company building a portfolio of products for either unmet medical needs or to replace currently available therapies with significant advantages. The company currently has six clinical stage candidates along with nine products in various preclinical … Continue reading

Posted in Small Cap News | Leave a comment

SciClone Pharmaceuticals, Inc. (SCLN) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

SciClone Pharmaceuticals is a specialty pharmaceutical company with a substantial commercial business in China, as well as a product portfolio of therapies for oncology, infectious diseases, and cardiovascular, urological, respiratory and central nervous system disorders. The company’s ZADAXIN (thymalfasin) has … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Lantronix, Inc. (LTRX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Lantronix is a leading global provider of secure communication technologies that streamline M2M access and communication. The company’s connectivity solutions facilitate data sharing between devices and applications to help businesses make better decisions through real-time information, as well as empower … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Verastem, Inc. (VSTM) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Verastem is a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells. The company’s products candidates include VS-507, currently in preclinical studies for the treatment for breast cancer; and VS-4718 … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Energy Focus, Inc. (EFOI) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Energy Focus is a global leader in providing energy-efficient LED lighting products and energy-efficient lighting solutions. The company holds 75 relevant lighting patents, and Energy Focus’ solutions offer energy saving, aesthetics, safety and maintenance cost benefits over conventional lighting. The … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment